RUNX1 and leukemia: Considering that the JmjC domain was demonstrated to be critical for the t(8;21) AML survival by functioning as a cofactor for AML1-ETO (Chen et al., 2015), we first examined if the JmjC domain is also critical for other types of leukemia.